BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11127916)

  • 1. Immunohistochemical detection of CD10 in paraffin sections of hematopoietic neoplasms: a comparison with flow cytometry detection in 56 cases.
    Chu PG; Chang KL; Weiss LM; Arber DA
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):257-62. PubMed ID: 11127916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of CD10 with monoclonal antibody 56C6 on paraffin sections.
    Kaufmann O; Flath B; Späth-Schwalbe E; Possinger K; Dietel M
    Am J Clin Pathol; 1999 Jan; 111(1):117-22. PubMed ID: 9894462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoperoxidase detection of CD10 in Precursor T-lymphoblastic lymphoma/leukemia: a clinicopathologic study of 24 cases.
    Conde-Sterling DA; Aguilera NS; Nandedkar MA; Abbondanzo SL
    Arch Pathol Lab Med; 2000 May; 124(5):704-8. PubMed ID: 10782151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD10 expression in follicular lymphoma versus reactive follicular hyperplasia: evaluation in paraffin-embedded tissue.
    Barcus ME; Karageorge LS; Veloso YL; Kornstein MJ
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):263-6. PubMed ID: 11127917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
    Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
    Hanson CA; Ross CW; Schnitzer B
    Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
    de Leon ED; Alkan S; Huang JC; Hsi ED
    Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.
    Eshoa C; Perkins S; Kampalath B; Shidham V; Juckett M; Chang CC
    Am J Clin Pathol; 2001 Jun; 115(6):862-7. PubMed ID: 11392883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry.
    Kurtin PJ; Hobday KS; Ziesmer S; Caron BL
    Am J Clin Pathol; 1999 Sep; 112(3):319-29. PubMed ID: 10478136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
    Chu P; Arber DA
    Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł; Bulsa J; Sonsala A; Twardoch M; Wieczorek M; Malinowska I; Derwich K; Niedźwiecki M; Sobol-Milejska G; Kowalczyk JR; Mazur B; Szczepański T
    Cytometry B Clin Cytom; 2014 Sep; 86(5):329-39. PubMed ID: 24845957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-Cell lymphomas.
    Xu Y; McKenna RW; Kroft SH
    Mod Pathol; 2002 Apr; 15(4):413-9. PubMed ID: 11950915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotyping of acute lymphoblastic leukemia using immunohistochemistry in bone marrow biopsy specimens.
    Al Gwaiz LA; Bassioni W
    Histol Histopathol; 2008 Oct; 23(10):1223-8. PubMed ID: 18712674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue.
    McIntosh GG; Lodge AJ; Watson P; Hall AG; Wood K; Anderson JJ; Angus B; Horne CH; Milton ID
    Am J Pathol; 1999 Jan; 154(1):77-82. PubMed ID: 9916921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
    Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
    Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma.
    Schniederjan SD; Li S; Saxe DF; Lechowicz MJ; Lee KL; Terry PD; Mann KP
    Am J Clin Pathol; 2010 May; 133(5):718-26. PubMed ID: 20395518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).
    Rodig SJ; Abramson JS; Pinkus GS; Treon SP; Dorfman DM; Dong HY; Shipp MA; Kutok JL
    Clin Cancer Res; 2006 Dec; 12(23):7174-9. PubMed ID: 17145843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.